Finally, to validate the potential mechanism of HQ, FMNT and CS against colon cancer, molecular docking was further performed to explore the binding affinity of FMNT and CS with upstream molecules of ERK1/2 pathway. Here, MAPK3 is linked to colonic neoplasm.